Clinical Trial Update: Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Brentuximab Vedotin (Adcetris) in combination with chemotherapy and radiation for younger patients with Stage IIB, IIIB, and IV Hodgk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Stage II Childhood Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-02-08